Eyepoint Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 17, 2026 Gain 3.88%

The EyePoint Pharmaceuticals Inc. stock price fell by -0.365% on the last day (Friday, 26th Jun 2026) from $13.71 to $13.66. During the last trading day the stock fluctuated 4.07% from a day low at $13.52 to a day high of $14.07. The price has risen in 7 of the last 10 days and is up by 9.28% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.11% during the next 3 months and, with a 90% probability hold a price between $10.26 and $13.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

EYPT Signals & Forecast

The EyePoint Pharmaceuticals Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $13.80. On a fall, the stock will find some support from the long-term average at approximately $12.96. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 24, 2026, and so far it has fallen -5.14%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for EyePoint Pharmaceuticals Inc. stock

EyePoint Pharmaceuticals Inc. finds support from accumulated volume at $13.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.550 between high and low, or 4.07%. For the last week the stock has had daily average volatility of 6.12%

Our recommended stop-loss: $12.90 (-5.53%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (EYPT) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect EyePoint Pharmaceuticals Inc. to open at $13.75, and during the day (based on 14 day Average True Range), to move between $13.26 and $14.06, which gives a possible trading interval of +/-$0.81 (+/-6.09%) up or down from last closing price. If EyePoint Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 6.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.71 (0.37%) than the support at $13.58 (0.59%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is EyePoint Pharmaceuticals Inc. stock A Buy?

EyePoint Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.418 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $13.75 ( 0.659%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk